In Part 1 of this three-part series, we interview Alice Zhang, CEO of Verge Genomics, on the use of artificial intelligence to develop treatments for amyotrophic lateral sclerosis and other neurological disorders . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post Front Row Series 2: AI in Drug Discovery and Development appeared first on GEN – Genetic Engineering and Biotechnology News.
